Baxter International Inc.
BAX
Get informed when a big investor buys or sells
+ FollowMarket Cap$13.07B
Close$
$23.46
5% downside
Current Fair Value
5% downsideOvervalued by 5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $13.07 Billion |
|---|---|
| Enterprise Value | $20.59 Billion |
| Dividend Yield | $0.04 (0.16%) |
| Earnings per Share | $-1.75 |
| Beta | 0.65 |
| Outstanding Shares | 517,000,000 |
Return
| Return on Equity | -15.63% |
|---|---|
| Return on Assets | -4.90% |
| Return on Invested Capital | 2.56% |
Valuation & Multiples
| P/E Ratio | -12.4 |
|---|---|
| PEG | 22.81 |
| Price to Sales | 1.12 |
| Price to Book Ratio | 2.25 |
| Enterprise Value to Revenue | 1.79 |
| Enterprise Value to EBIT | 49.73 |
| Enterprise Value to Net Income | -22 |
| Total Debt to Enterprise | 0.47 |
| Debt to Equity | 1.56 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 30, 2026
EPS Estimate
$0.37
Average shareholder expectationRevenue Estimate
$2.80 B
Average shareholder expectationNext Earnings Call
Expected Date
October 29, 2026
EPS Estimate
$0.52
Average shareholder expectationRevenue Estimate
$2.91 B
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 65.12% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.86%▼ 108.38% |
|---|---|
| Total Invested | $105.67M▼ 99.12% |
| Investors Holding | 78▼ 644.00% |
ESG Score
No data
About Baxter International Inc.
37,500 employees
CEO: Jose Almeida Baxter International Inc. is a global healthcare company that develops and supplies a broad spectrum of medical products and services through its various subsidiaries. The company's offerings encompass vital areas such as kidney care, in...